Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1980 Jun;43(6):483–488. doi: 10.1136/jnnp.43.6.483

Myasthenic syndrome: effect of choline, plasmapheresis and tests for circulating factor.

H Kranz, D J Caddy, A M Williams, W Gay
PMCID: PMC490587  PMID: 6110709

Abstract

In a patient with myasthenic syndrome neuro-muscular transmission was characterised by depression and facilitation. The relative extent of these two processes varied between muscles, and in the one muscle with time. Guanidine HCl treatment corrected the electrophysiological defect. Oral choline increased muscle action potential amplitude in response to single shocks. Intravenous choline produced features indicating cholinergic autonomic stimulation. Pimozide and plasmapheresis had no effect. Animal in-vivo and in-vitro studies performed to detect a circulating factor which interferes with neuro-muscular transmission were negative.

Full text

PDF
483

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aquilonius S. M., Flentge F., Schuberth J., Sparf B., Sundwall A. Synthesis of acetylcholine in different compartments of brain nerve terminals in vivo as studied by the incorporation of choline from plasma and the effect of pentobarbital on this process. J Neurochem. 1973 Jun;20(6):1509–1521. doi: 10.1111/j.1471-4159.1973.tb00269.x. [DOI] [PubMed] [Google Scholar]
  2. Balnave R. J., Gage P. W. Temperature sensitivity of the time course of facilitation of transmitter release. Brain Res. 1970 Jul 14;21(2):297–300. doi: 10.1016/0006-8993(70)90374-4. [DOI] [PubMed] [Google Scholar]
  3. Borenstein S., Desmedt J. E. Temperature and weather correlates of myasthenic fatigue. Lancet. 1974 Jul 13;2(7872):63–66. doi: 10.1016/s0140-6736(74)91632-8. [DOI] [PubMed] [Google Scholar]
  4. Cohen E. L., Wurtman R. J. Brain acetylcholine: control by dietary choline. Science. 1976 Feb 13;191(4227):561–562. doi: 10.1126/science.1251187. [DOI] [PubMed] [Google Scholar]
  5. Dau P. C., Lindstrom J. M., Cassel C. K., Denys E. H., Shev E. E., Spitler L. E. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. N Engl J Med. 1977 Nov 24;297(21):1134–1140. doi: 10.1056/NEJM197711242972102. [DOI] [PubMed] [Google Scholar]
  6. Elmqvist D., Lambert E. H. Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma. Mayo Clin Proc. 1968 Oct;43(10):689–713. [PubMed] [Google Scholar]
  7. GINSBORG B. L., WARRINER J. The isolated chick biventer cervicis nerve-muscle preparation. Br J Pharmacol Chemother. 1960 Sep;15:410–411. doi: 10.1111/j.1476-5381.1960.tb01264.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ganguly D. K., Das M. Effects of oxotremorine demonstrate presynaptic muscarinic and dopaminergic receptors on motor nerve terminals. Nature. 1979 Apr 12;278(5705):645–646. doi: 10.1038/278645a0. [DOI] [PubMed] [Google Scholar]
  9. Growdon J. H., Hirsch M. J., Wurtman R. J., Wiener W. Oral choline administration to patients with tardive dyskinesia. N Engl J Med. 1977 Sep 8;297(10):524–527. doi: 10.1056/NEJM197709082971002. [DOI] [PubMed] [Google Scholar]
  10. Haubrich D. R., Wang P. F., Wedeking P. W. Distribution and metabolism of intravenously administered choline[methyl- 3-H] and synthesis in vivo of acetylcholine in various tissues of guinea pigs. J Pharmacol Exp Ther. 1975 Apr;193(1):246–255. [PubMed] [Google Scholar]
  11. Kamenskaya M. A., Elmqvist D., Thesleff S. Guanidine and neuromuscular transmission. I. Effect on transmitter release occurring spontaneously and in response to single nerve stimuli. Arch Neurol. 1975 Aug;32(8):505–509. doi: 10.1001/archneur.1975.00490500025001. [DOI] [PubMed] [Google Scholar]
  12. Kuhar M. J., Sethy V. H., Roth R. H., Aghajanian G. K. Choline: selective accumulation by central cholinergic neurons. J Neurochem. 1973 Feb;20(2):581–593. doi: 10.1111/j.1471-4159.1973.tb12157.x. [DOI] [PubMed] [Google Scholar]
  13. Lambert E. H. Defects of neuromuscular transmission in syndromes other than myasthenia gravis. Ann N Y Acad Sci. 1966 Jan 26;135(1):367–384. doi: 10.1111/j.1749-6632.1966.tb45484.x. [DOI] [PubMed] [Google Scholar]
  14. Lambert E. H., Elmqvist D. Quantal components of end-plate potentials in the myasthenic syndrome. Ann N Y Acad Sci. 1971 Sep 15;183:183–199. doi: 10.1111/j.1749-6632.1971.tb30750.x. [DOI] [PubMed] [Google Scholar]
  15. Magleby K. L., Zengel J. E. Stimulation-induced factors which affect augmentation and potentiation of trasmitter release at the neuromuscular junction. J Physiol. 1976 Sep;260(3):687–717. doi: 10.1113/jphysiol.1976.sp011539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mori M., Takamori M. Hyperthyroidism and myasthenia gravis with features of Eaton-Lambert syndrome. Neurology. 1976 Sep;26(9):882–887. doi: 10.1212/wnl.26.9.882. [DOI] [PubMed] [Google Scholar]
  17. Ricker K., Hertel G., Stodieck S. The influence of local cooling on neuromuscular transmission in the myasthenic syndrome of Eaton and Lambert. J Neurol. 1977 Dec 13;217(2):95–102. doi: 10.1007/BF00312922. [DOI] [PubMed] [Google Scholar]
  18. Schwartz M. S., Stålberg E. Myasthenia gravis with features of the myasthenic syndrome. An investigation with electrophysiologic methods including single-fiber electromyography. Neurology. 1975 Jan;25(1):80–84. doi: 10.1212/wnl.25.1.80. [DOI] [PubMed] [Google Scholar]
  19. Takamori M., Gutmann L. Intermittent defect of acetylcholine release in myasthenia gravis. Neurology. 1971 Jan;21(1):47–54. doi: 10.1212/wnl.21.1.47. [DOI] [PubMed] [Google Scholar]
  20. Ulus I. H., Wurtman R. J. Choline administration: activation of tyrosine hydroxylase in dopaminergic neurons of rat brain. Science. 1976 Dec 3;194(4269):1060–1061. doi: 10.1126/science.10629. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES